Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 25, Number 42, 2019

Editorial

Favourites:
ADD

Review article

Methods for the Determination of the Purity of Exosomes
pp. 4464-4485(22)
Authors: Kluszczyńska, Katarzyna; Czernek, Liliana; Cypryk, Wojciech; Pęczek, Łukasz; Düchler, Markus

Favourites:
ADD

Exosomes in Sepsis and Inflammatory Tissue Injury
pp. 4486-4495(10)
Authors: Park, Eun J.; Appiah, Michael G.; Myint, Phyoe K.; Gaowa, Arong; Kawamoto, Eiji; Shimaoka, Motomu

Favourites:
ADD

Exosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis
pp. 4496-4509(14)
Authors: Li, Mengyu; Jiang, Mao; Meng, Jie; Tao, Lijian

Favourites:
ADD

Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
pp. 4510-4522(13)
Authors: Longoni, Biancamaria; Fasciani, Irene; Kolachalam, Shivakumar; Pietrantoni, Ilaria; Marampon, Francesco; Petragnano, Francesco; Aloisi, Gabriella; Coppolino, Maria F.; Rossi, Mario; Scarselli, Marco; Maggio, Roberto

Favourites:
ADD

The Emerging Role of Exosomal Non-coding RNAs in Musculoskeletal Diseases
pp. 4523-4535(13)
Authors: Tu, Chao; He, Jieyu; Chen, Ruiqi; Li, Zhihong

Favourites:
ADD

Exosomes and Bone Disease
pp. 4536-4549(14)
Authors: Shan, Su-Kang; Lin, Xiao; Li, Fuxingzi; Xu, Feng; Zhong, Jia-Yu; Guo, Bei; Wang, Yi; Zheng, Ming-Hui; Wu, Feng; Yuan, Ling-Qing

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content